Renal Cancer - Results from #6060

Therapeutic challenges in renal cell carcinoma September 1, 2015

Health Care Costs Among Renal Cancer Patients Using Pazopanib and Sunitinib September 1, 2015

Cost-Effectiveness of Pazopanib Versus Sunitinib for Renal Cancer in the United States September 1, 2015

Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality Following Radical Nephrectomy for Localized Renal Cell Cancer September 1, 2015

Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study August 31, 2015

Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer August 28, 2015

miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib August 28, 2015

Pulmonary Metastasectomy 31 Years After Surgery for Renal Cell Carcinoma August 28, 2015

Diagnostic Significance of Diffusion-Weighted MRI in Renal Cancer August 27, 2015

Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas August 27, 2015

Genetic Variants in Caveolin-1 and RhoA/ROCK1 Are Associated with Clear Cell Renal Cell Carcinoma Risk in a Chinese Population August 27, 2015

Metastases to the Pancreas: Computed Tomography Imaging Spectrum and Clinical Features: A Retrospective Study of 18 Patients With 36 Metastases August 27, 2015

A review of high intensity focused ultrasound in relation to the treatment of renal tumours and other malignancies August 25, 2015

Inhibition of endogenous hydrogen sulfide production in clear-cell renal cell carcinoma cell lines and xenografts restricts their growth, survival and angiogenic potential August 25, 2015

The immunocheckpoints in modern oncology: the next 15 years August 25, 2015

Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma August 25, 2015

High-Dose Sirolimus And Immune Selective Pentostatin Plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-Versus-Tumor Responses August 24, 2015

Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment August 24, 2015

Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinoma August 24, 2015

Biomarkers for evaluating racial disparities in clinical outcome in patients with renal cell carcinoma August 23, 2015

Page 304 of 457